112 related articles for article (PubMed ID: 1381276)
1. Inhibition of angiogenesis by suramin.
Gagliardi A; Hadd H; Collins DC
Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis by aurintricarboxylic acid.
Gagliardi AR; Collins DC
Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
Chen NT; Corey EJ; Folkman J
Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis through modulation of collagen metabolism.
Ingber D; Folkman J
Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
Maragoudakis ME; Sarmonika M; Panoutsacopoulou M
J Pharmacol Exp Ther; 1989 Nov; 251(2):679-82. PubMed ID: 2478695
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
Sakamoto N; Tanaka NG
Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551
[TBL] [Abstract][Full Text] [Related]
7. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Hazel SJ
J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
9. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
[TBL] [Abstract][Full Text] [Related]
10. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
11. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.
Ingber DE; Madri JA; Folkman J
Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602
[TBL] [Abstract][Full Text] [Related]
12. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
Ribatti D; Vacca A; Roncali L; Dammacco F
Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
[TBL] [Abstract][Full Text] [Related]
13. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
Bahramsoltani M; Plendl J
APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
[TBL] [Abstract][Full Text] [Related]
14. [Demonstration of the vasoproliferative activity of heparin on chorioallantoic membrane].
Ribatti D; Nico B; Roncali L
Boll Soc Ital Biol Sper; 1985 Sep; 61(9):1287-93. PubMed ID: 2416328
[No Abstract] [Full Text] [Related]
15. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.
Wilks JW; Scott PS; Vrba LK; Cocuzza JM
Int J Radiat Biol; 1991; 60(1-2):73-7. PubMed ID: 1713944
[No Abstract] [Full Text] [Related]
17. [The modifying action of tumor necrosis factor on angiogenesis].
Lisniak IA; Sopotsinskaia EB; Kudriavets IuI
Eksp Onkol; 1989; 11(3):50-2. PubMed ID: 2473876
[TBL] [Abstract][Full Text] [Related]
18. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo.
McNatt LG; Lane D; Clark AF
J Steroid Biochem Mol Biol; 1992 Aug; 42(7):687-93. PubMed ID: 1380295
[TBL] [Abstract][Full Text] [Related]
19. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
20. Suramin analogs inhibit human angiogenesis in vitro.
Meyers MO; Gagliardi AR; Flattmann GJ; Su JL; Wang YZ; Woltering EA
J Surg Res; 2000 Jun; 91(2):130-4. PubMed ID: 10839961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
